scholarly journals The extended/phase II study of safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate resistant prostate cancer (mCRPC) who failed either abiraterone (Abi) or enzalutamide (Enza)

2019 ◽  
Vol 30 ◽  
pp. v355 ◽  
Author(s):  
N.J. Vogelzang ◽  
N. Gabrail ◽  
Z. Malik ◽  
F. Volterra ◽  
L.T. Nordquist ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Extended Phase ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant

scholarly journals A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer

2021 ◽  
Vol 143 ◽  
pp. 112226
Author(s):  
Eric Zhuang ◽  
Edward Uchio ◽  
Michael Lilly ◽  
Xiaolin Zi ◽  
John P. Fruehauf
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant

674 DELAYED PSA RESPONSES IN PERSONALIZED PEPTIDE VACCINATION FOR CASTRATE-RESISTANT PROSTATE CANCER PATIENTS PHASE II STUDY

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Masanori Noguchi ◽  
Fukuko Moriya ◽  
Shigetaka Suekane ◽  
Kei Matsuoka ◽  
Satoko Matsueda ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Peptide Vaccination ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant

Updated analysis of a phase II study using sorafenib (S) for metastatic castrate-resistant prostate cancer (mCRPC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16026-16026
Author(s):  
J. B. Aragon-Ching ◽  
L. Jain ◽  
D. Draper ◽  
J. L. Gulley ◽  
P. M. Arlen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant
Sign in / Sign up

Export Citation Format

Share Document